Fisher & Paykel Healthcare Corporation Limited
Symbool: FPH.AX
ASX
23.66
AUDMarktprijs vandaag
61.8116
Koers/Winst Verhouding
3.7087
Koers/Winst Groei Verhouding
13.82B
MRK Kapitalisatie
- 0.01%
DIV Rendement
Fisher & Paykel Healthcare Corporation Limited (FPH-AX) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 113.3 | 268.5 | 347.2 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0.5 | 185.3 | 257.7 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 237.9 | 169.2 | 210.5 | |||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 342.4 | 332.4 | 248.8 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 31.1 | 52.2 | 39.4 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 724.6 | 822.4 | 846 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1074.7 | 887.2 | 811.1 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 80.1 | 80.4 | 73.6 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 80.1 | 80.4 | 73.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 93.5 | 84.2 | 102.6 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 90.4 | 77.4 | 74.8 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1338.7 | 1129.2 | 1062 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 2063.4 | 1951.6 | 1908 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 40.2 | 49.8 | 52.1 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 19.9 | 15.7 | 24.5 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 6.2 | 29.5 | 137.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 74 | 58.4 | 57.7 | |||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 42.5 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 204.9 | 186.4 | 178.9 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 151 | 114.3 | 116.4 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 42.5 | 22.5 | 26.7 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 422.2 | 395.8 | 509.5 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 287.3 | 246.7 | 231.1 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 1123.6 | 1094.1 | 946.4 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 233.2 | 219.8 | 223.1 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -3.1 | -4.7 | -2 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1641.1 | 1555.9 | 1398.5 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 2063.4 | 1951.6 | 1908 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 1641.1 | 1555.9 | 1398.5 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||||
Total Investments | 0 | 93.5 | 269.5 | 360.4 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 136.5 | 96.6 | 108.9 | |||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 23.2 | 13.3 | 19.4 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 234.3 | 349.1 | 482 | |||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 92.7 | 88.9 | 78.2 | |||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 4.5 | -6.3 | -54.3 | |||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -250.1 | -216.3 | -214.7 | |||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -64.8 | -38.4 | -58.4 | |||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -40.5 | 48.6 | -4.7 | |||||||||||||||||||||||
cash-flows.row.inventory | 0 | -6.5 | -81.8 | -114.1 | |||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -17.8 | -5.3 | 60.4 | |||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 206.4 | 123.4 | 342.2 | |||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -197.8 | -157.3 | -169.8 | |||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -186.3 | |||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 187.2 | 74.4 | 0 | |||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -10.6 | -82.9 | -356.1 | |||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -9.4 | -0.1 | -45.3 | |||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 2.8 | 3 | 3.2 | |||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0.9 | 1 | 46.1 | |||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -183.2 | -208.3 | -166.7 | |||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 4.3 | -14 | -10.2 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -184.5 | -218.4 | -172.9 | |||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 2.4 | 0.2 | -1 | |||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 30 | -6.2 | 24.5 | |||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 113.3 | 83.3 | 89.5 | |||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 83.3 | 89.5 | 65 | |||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 222.9 | 300.4 | 575 | |||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -197.8 | -157.3 | -169.8 | |||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 25.2 | 143.1 | 405.1 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1486.9 | 1521.3 | 1791.4 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 601.6 | 582.6 | 667.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 885.3 | 938.7 | 1124.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -7.6 | 40.2 | 32.4 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 567.4 | 506.8 | 490.4 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1168.9 | 1089.4 | 1157.6 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 2.4 | 2.4 | 1.4 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 6.3 | 4.5 | 4.6 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -11 | 35.1 | 26.6 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -7.6 | 40.2 | 32.4 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -11 | 35.1 | 26.6 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 6.3 | 4.5 | 4.6 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 92.7 | 88.9 | 78.2 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | 318 | 431.9 | 633.8 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 307 | 467 | 660.4 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 72.7 | 117.9 | 178.4 | |||||||||||||||||||||||
income-statement-row.row.net-income | 0 | 250.3 | 376.9 | 524.2 |
Vaak gestelde vragen
Wat is Fisher & Paykel Healthcare Corporation Limited (FPH.AX) totale activa?
Fisher & Paykel Healthcare Corporation Limited (FPH.AX) totale activa is 2063359237.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.601.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.153.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.219.
Wat is Fisher & Paykel Healthcare Corporation Limited (FPH.AX) nettowinst (netto-inkomen)?
De nettowinst is 250300000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 136465310.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 567388691.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.